Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease
Public ClinicalTrials.gov record NCT02847650. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 15-WEEK, PHASE 2, DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED, FLEXIBLE DOSE STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF PF-06649751 IN SUBJECTS WITH EARLY STAGE PARKINSON'S DISEASE
Study identification
- NCT ID
- NCT02847650
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 57 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- PF-06649751 Drug
Drug
Eligibility (public fields only)
- Age range
- 45 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 16, 2016
- Primary completion
- Jan 28, 2018
- Completion
- Jan 28, 2018
- Last update posted
- Nov 22, 2020
2016 – 2018
United States locations
- U.S. sites
- 20
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St Joseph's Hospital and Medical Center, Barrow Neurology Clinics | Phoenix | Arizona | 85013 | — |
| St. Joseph's Hospital and Medical Center | Phoenix | Arizona | 85013 | — |
| Parkinson's Disease and Movement Disorders Center of Boca Raton | Boca Raton | Florida | 33486 | — |
| University of Miami | Miami | Florida | 33136 | — |
| University of South Florida Carol and Frank Morsani Center for Advanced Health Care | Tampa | Florida | 33612 | — |
| University of South Florida Faculty Office Building | Tampa | Florida | 33612 | — |
| University of South Florida | Tampa | Florida | 33612 | — |
| University of South Florida Parkinson's Disease and Movement Disorders Center | Tampa | Florida | 33613 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Asheville Neurology Specialists PA | Asheville | North Carolina | 28806 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| University of Toledo, Gardner-McMaster Parkinson Center | Toledo | Ohio | 43614 | — |
| University of Toledo | Toledo | Ohio | 43614 | — |
| AS Clinical Research Consultants of North Texas, PLLC | Greenville | Texas | 75401 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Sentara Neurology Specialists | Virginia Beach | Virginia | 23456 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02847650, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 22, 2020 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02847650 live on ClinicalTrials.gov.